ADP raised its fiscal 2027 outlook after a stronger first quarter. Payroll activity and interest on client funds offer different clues.
Lifelong Learning is the path to Insights
ADP raised its fiscal 2027 outlook after a stronger first quarter. Payroll activity and interest on client funds offer different clues.
Teradyne’s results show rapid growth in semiconductor testing, while robotics remains a smaller business. Here is what investors should watch.
Boston Scientific reported modest sales growth and lower earnings. Here is how to assess disruption, guidance and the recovery without guessing.
Amphenol posted sharply higher sales and a strong order book. The gap between reported and organic growth helps investors assess the result.
GE Vernova’s orders and backlog surged as it raised its outlook and agreed to buy Trench. Here is what the figures do—and do not—tell investors.
Oracle and OpenAI announced tools connecting AI to business systems. The practical questions are access, oversight and reliable execution.
Researchers have developed cacao with improved disease tolerance in laboratory tests. Field trials will determine whether it can help growers.
A mosquito study connects a gene to hearing and mating behavior. The finding could inform future research, but is not a deployed control method.
A large NIH-funded atlas maps gene activity across brain cells and diseases, offering clues while leaving major treatment questions open.
MIT researchers are testing folded, modular structures that could use less material. A large sculpture shows promise, but shelters need more testing.